Metacognitive Therapy, Neurofeedback and Treatment With Fluvoxamine on Cognitive Attentional Syndrome and Cognitive Emotion Regulation Strategies in Patients With Obsessive-Compulsive Disorder | Zendy

Hasan Bani Asadi | Zendy; Mahjoubeh Pourebrahimi | Zendy; Reza Amirteymoori | Zendy

Open Access

Metacognitive Therapy, Neurofeedback and Treatment With Fluvoxamine on Cognitive Attentional Syndrome and Cognitive Emotion Regulation Strategies in Patients With Obsessive-Compulsive Disorder

Author(s) -

Hasan Bani Asadi,

Mahjoubeh Pourebrahimi,

Reza Amirteymoori

Publication year - 2016

Publication title -

avicenna journal of neuro psych physiology

Language(s) - English

Resource type - Journals

eISSN - 2383-2444

pISSN - 2383-2436

DOI - 10.5812/ajnpp.41670

Subject(s) - fluvoxamine , neurofeedback , cognition , psychology , psychotherapist , metacognition , clinical psychology , medicine , cognitive psychology , psychiatry , electroencephalography , fluoxetine , receptor , serotonin

Background: Due to the lack of enough researches on the impaired underlying mechanisms in the obsessive-compulsive disorder (OCD) and also existence of new psychological therapies such as metacognitive therapy and neurofeedback, the application of mentioned mechanisms in the new therapies can be introduced as a possible effective option with more long term effects to treat

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research